Daniela Žáčková
@Danielakov2
Followers
62
Following
698
Media
6
Statuses
82
Associate professor & Deputy head for education/Dpt. of Internal Medicine, Hematology and Oncology @FNBrno @muni_cz /chronic myeloid leukemia🩺🩸📊🧬
Joined May 2022
Thank you @EHA_Hematology for the honour to co-chair the #CML Hematology-in-Focus session🙏Loved every minute!🧬🗨️.Good bye #EHA2025👋 Another amazing congress full of insights and inspiring encounters💡🤝 Can't wait for #EHA2026 🚀🩵.@FNBrno @muni_cz @EHA_Hematology
0
0
8
So honored to be part of the #ESHCML2025 faculty in Estoril 🇵🇹, October 10–12!🙏 Thanks to @GCC_Cortes, @ESHaematology and @icmlf for this opportunity 🙏 Thrilled to join such an amazing group – can’t wait! 🌟.#ESHCML2025 #CML .@ESHaematology @icmlf @FNBrno @muni_cz.
📣MEET THE CONFIRMED FACULTY OF #ESHCML2025!.Join them on Oct. 10-12, 2025 in Estoril, Portugal.To register & for more information➡️ESH-#iCMLf 27th John Goldman Conference on #CMLsm.Chairs: @GCC_Cortes @timhughesCML Daniela S. Krause.#ESHCONFERENCES @icmlf
2
1
6
RT @DrRaulCordoba: 🔈🔉🔊 Apply for @EHA_Hematology “Clinical Research Training in #Hematology” #CRTH . This program provides early-career #re….
0
9
0
Big thanks @icmlf for all the effort and great summaries from #EHA2025 🙏👍👌Really appreciate it🙏🙏.@icmlf @EHA_Hematology @muni_cz @FNBrno.
Day 3 update from #EHA2025 is now live!. Today’s Hematology-in-Focus: Chronic Myeloid Leukemia session, chaired by Daniela Žáčková and Giora Sharf, brought expert insights into resistance and treatment sequencing in CML. Catch the full update here:.👉
0
0
3
RT @ESHaematology: 🔔 BREAKING NEWS!.#ESHCMLMPN2025: VIDEOS & PRESENTATIONS NOW AVAILABLE TO ALL FOR FREE ON #ESHELEARNING.Enjoy viewing ➡ h….
0
5
0
RT @ESHaematology: 📣#ESHCML2025: CALL FOR LATE-BREAKING ABSTRACTS!.Deadline: June 30, 2025.Proceed here➡️ESH-#iCMLf….
0
6
0
RT @doctorpemm: #ASCO25 Prof Andreas Hochhaus | #ASC4START #asciminib met its primary endpoint vs nilotinib in newly dx patients with CML #….
0
7
0
RT @ESHaematology: #ESHCML2025: DEADLINE TO SUBMIT YOUR ABSTRACT APPROACHING: May 22nd.PROCEED NOW & be part of the ESH-#iCMLf 27th John Go….
0
3
0
RT @jyoti_nangalia: The potency of abnormal genetic fusion in chronic myeloid leukaemia in our latest study @Nature 👉🏽 .
0
39
0
RT @ESHaematology: 📣 #ESHCML2025 REMINDER: CALL FOR ABSTRACTS!.Join us to share your latest research at the ESH-#iCMLf 27th John Goldman Co….
0
7
0
It was a pleasure to join the interview on #TKI dose reduction before attempting #TFR in #CML patients - thanks @VJHemOnc! 🙏📽️🩸💊🩺.
We recently had the pleasure of speaking with @Danielakov2 of @MasarykUni to hear about TKI dose reduction before treatment-free remission in patients with CML. Want to learn more?. Watch the interview here:.🎥 #CMLsm #Leusm #HemOnc #ESHCMLMPN2025.
0
1
3
RT @VJHemOnc: Do you want to hear the most up-to-date information regarding the practical management of CML, MPN, & related conditions?🩸🏥….
0
1
0
RT @VJHemOnc: #ESHCMLMPN2025 | Prof. Giuseppe Saglio of @unito comments on the use of asciminib as a first-line treatment for patients with….
0
1
0
🎬Happy to share interviews from #ESHCMLMPN2025 conference, where I had the opportunity to introduce the Czech nationwide #HALF trial. 🙏Thanks to @VJHemOnc for the coverage! .👇Whatch here:.#CML #TKI #TFR .@ESHaematology .@FNBrno .@muni_cz.@czecrin.
0
0
3
Honored to speak at #ESHCMLMPN2025 conference in Vienna on #TKI dose reduction before #TFR & Czech study #HALF.🎤🙌 .Big thanks to @ESHorg, chairs @AndreasHochhaus @harrisoncn1 @mpdrc, faculty & audience for a great conference! 🙌👏🎉.#CML @ESHaematology @FNBrno @muni_cz @czecrin
0
1
7
RT @VJHemOnc: The 4th ESH How to Diagnose & Treat: CML/MPN Meeting is kicking off today!🇦🇹. Although we can't be there in person, we are co….
0
1
0
RT @ESHaematology: Our Team is ready to welcome you in Vienna for the 4th How to Diagnose and Treat CML/MPN.Registration opens at 7:45am CE….
0
9
0
RT @ESHaematology: 📣 #ESHCML2025 CALL FOR ABSTRACTS!. Join us to share your latest research at the ESH-#iCMLf 27th John Goldman Conference….
0
5
0